Related Experiment Video
Updated: Jul 10, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
[Sentinel lymph node biopsy and breast cancer]
Anders Husted Madsen1, Eva Balslev, Hanne Galatius
1Arhus Universitetshospital, Kirurgisk Afdeling P. husted@ki.au.dk
Ugeskrift for Laeger
|October 24, 2007
Summary
Sentinel lymph node biopsy is now standard for breast cancer, changing its indications and techniques. This review updates surgical methods, pathology, and patient outcomes like morbidity, recurrence, and mortality.
Area of Science:
- Oncology
- Surgical Pathology
- Clinical Medicine
Context:
- Sentinel lymph node biopsy (SLNB) has become a standard procedure for breast cancer staging.
- Evolving clinical practice necessitates updates on SLNB indications and techniques.
Purpose:
- To provide a comprehensive review of current sentinel lymph node biopsy practices in breast cancer treatment.
- To update information on surgical techniques, histopathology, morbidity, recurrence, and mortality associated with SLNB.
Summary:
- The implementation of sentinel lymph node biopsy (SLNB) has led to changes in its indications and surgical techniques for breast cancer.
- This review details advancements in surgical procedures, histopathological analysis, and associated patient outcomes.
- Key aspects covered include morbidity rates, cancer recurrence, and overall mortality following SLNB.
Impact:
- Informs clinicians about the latest advancements in sentinel lymph node biopsy for breast cancer management.
- Aims to optimize surgical techniques and patient care, potentially improving outcomes.
- Contributes to the ongoing understanding of SLNB's role in reducing morbidity and mortality in breast cancer patients.
